After an hour of deliberation Friday and four weeks of trial, a Philadelphia jury will continue its work today in a lawsuit over whether drugmaker Wyeth’s hormonal drug caused an Alabama plaintiff’s breast cancer.
The verdict in Singleton v. Wyeth will either continue or disrupt the run of jury verdicts in favor of plaintiffs in Philadelphia hormone-replacement therapy cases. There are 1,500 HRT mass tort cases pending in Philadelphia Common Pleas Court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
